Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Loreev price, strengths & recalls

Brand of lorazepam (generic)

Pharmacies pay $426.84 for 30 capsules of Loreev 1 mg (24 hr) extended-release capsule this week, and from $425.36 to $426.84 across its 4 priced strengths and forms. The generic, lorazepam, costs pharmacies from $1.09. It is in shortage (unavailable). It has 21 recalls on record, none ongoing. Its official label last changed on October 9, 2026.

UnavailableBrand
Pharmacies pay$426.84for 30 capsules of 1 mg (24 hr) extended-release capsule+0.1% in 4 weeks
Fair cash price
$501.37
Strengths
4
Makers
1
Updated
Nov 11

Loreev price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
1 mg (24 hr) extended-release capsule Brand$14.23$426.84 / 30 capsules+0.1%-0.1%
1.5 mg (24 hr) extended-release capsule Brand$14.22$426.52 / 30 capsules-0.2%-0.3%
2 mg (24 hr) extended-release capsule Brand$14.18$425.36 / 30 capsules-0.1%-0.5%
3 mg (24 hr) extended-release capsule Brand$14.22$426.71 / 30 capsulesNo changeNo change

The lowest cost per capsule is 2 mg (24 hr) extended-release capsule at $14.18. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Loreev vs generic lorazepam

GenericLorazepam prices

Supply status: shortages & recalls

In shortage11 products are short or being discontinued
7 ongoing recalls21 recalls on record

Shortages

  • Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Demand increase for the drug · Updated Nov 9, 2026Limited Supply Available. Next Delivery and Estimated Recovery: June 2027
  • Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1)Amphastar Pharmaceuticals, Inc. · Available · Updated Nov 6, 2026
  • Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25)Hikma Pharmaceuticals USA, Inc. · Limited Availability · Reason: Demand increase for the drug · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Oct 14, 2026Estimated recovery: TBD
  • Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Oct 14, 2026Estimated recovery: TBD
  • Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Oct 14, 2026Estimated recovery: TBD
  • Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25)Hikma Pharmaceuticals USA, Inc. · Limited Availability · Reason: Demand increase for the drug · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25)Hikma Pharmaceuticals USA, Inc. · Limited Availability · Reason: Demand increase for the drug · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Oct 14, 2026Estimated recovery: TBD
  • Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25)Hikma Pharmaceuticals USA, Inc. · Limited Availability · Reason: Demand increase for the drug · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Showing the 6 most relevant of 21 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for loreev? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedOctober 9, 2026
Version6 of 6
EffectiveOct 8, 2025
Read the label

These highlights do not include all the information needed to use LOREEV XR safely and effectively. See full prescribing information for LOREEV XR. LOREEV XR (lorazepam) extended-release capsules, for oral use, CIV Initial U.S. Approval: 1977

This drug has a boxed warning

WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS

Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs for patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation [see Warnings and Precautions (5.1), Drug Interactions (7)].

The use of benzodiazepines, including LOREEV XR, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Abuse and misuse of benzodiazepines commonly involve concomitant use of other medications, alcohol, and/or illicit substances, which is associated with an increased frequency of serious adverse outcomes. Before prescribing LOREEV XR and throughout treatment, assess each patient's risk for abuse, misuse, and addiction [see Warnings and Precautions (5.2)].

The continued use of benzodiazepines, including LOREEV XR, may lead to clinically significant physical dependence. The risks of dependence and withdrawal increase with longer treatment duration and higher daily dose. Abrupt discontinuation or rapid dosage reduction of LOREEV XR after continued use may precipitate acute withdrawal reactions, which can be life-threatening. To reduce the risk of withdrawal reactions, use a gradual taper to discontinue LOREEV XR or reduce the dosage [see Dosage and Administration (2.4), Warnings and Precautions (5.3)].

WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS

See full prescribing information for complete boxed warning.

Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs for use in patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation (5.1, 7)

The use of benzodiazepines, including LOREEV XR, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Before prescribing LOREEV XR and throughout treatment, assess each patient's risk for abuse, misuse, and addiction (5.2)

Abrupt discontinuation or rapid dosage reduction of LOREEV XR after continued use may precipitate acute withdrawal reactions, which can be life-threatening. To reduce the risk of withdrawal reactions, use a gradual taper to discontinue LOREEV XR or reduce the dosage (2.4, 5.3)

Recent major changes (as listed on the label)

Warnings and Precautions (5.8) | 1/2023 |

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA214826 · Almatica
First approved
August 27, 2021 (5 years ago)
Latest approved change
January 13, 2023
Approved label
PDF, Jan 23, 2023
Generic makers
16 approved generic applications on the market
Last patent listed
January 8, 2034

Loreev questions

How much does loreev cost without insurance?

Pharmacies pay about $426.84 for 30 capsules of loreev 1 mg (24 hr) extended-release capsule ($14.23 per capsule). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $501.37. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Loreev?

Yes: lorazepam. Pharmacies pay from $1.09 for it. Compare lorazepam prices.

Is loreev in shortage?

Yes. 11 products are listed as in shortage or being discontinued (unavailable). See which ones.

Has loreev been recalled?

21 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the loreev label last change?

The official label was last updated on October 9, 2026 (version 6). See what changed.

Talk about loreev

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.